Fundraising Fox
/People
Sign in

Jim Sullivan, Ph.D.

Investor

Venture Partner at OrbiMed

Greater Chicago Area

Find your path to Jim

Sign up to see every warm intro you have to Jim

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Jim. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Jim Sullivan joined OrbiMed as a Venture Partner in 2019 and serves as CEO of portfolio company Vanqua Bio, which develops therapeutics for neurological conditions such as Parkinson's disease. He previously was Vice President of Research at AbbVie, overseeing research across oncology, immunology, neurology, hepatitis C, and cystic fibrosis, and has advanced more than 100 compounds into clinical development. He holds a bachelor's degree and Ph.D. in biochemistry from Trinity College Dublin, completed postdoctoral research in neurobiology at Northwestern University, and is an adjunct faculty member there.

Invests in

Biotech

Investments

Board seats

AliadaVanqua Bio

Per the firm's website.

Colleagues at OrbiMed

Alexander M. Cooper
Investor at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Bill Moschella
Venture Partner at OrbiMed
Bob Smith
Investor at OrbiMed
Brendan Weber
Principal at OrbiMed

Frequently asked questions

Who is Jim Sullivan, Ph.D.?
Jim Sullivan joined OrbiMed as a Venture Partner in 2019 and serves as CEO of portfolio company Vanqua Bio, which develops therapeutics for neurological conditions such as Parkinson's disease. He previously was Vice President of Research at AbbVie, overseeing research across oncology, immunology, neurology, hepatitis C, and cystic fibrosis, and has advanced more than 100 compounds into clinical development. He holds a bachelor's degree and Ph.D. in biochemistry from Trinity College Dublin, completed postdoctoral research in neurobiology at Northwestern University, and is an adjunct faculty member there.
Where does Jim Sullivan, Ph.D. work?
Jim Sullivan, Ph.D. is Venture Partner at OrbiMed.
What does Jim Sullivan, Ph.D. invest in?
Jim Sullivan, Ph.D. invests in Biotech.
What boards does Jim Sullivan, Ph.D. sit on?
Jim Sullivan, Ph.D. holds tracked board seats at Aliada, Vanqua Bio.

Founder mafias

About this profile. Compiled from public sources — OrbiMed's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights